Home/Filings/4/0001209191-23-002031
4//SEC Filing

Leavitt Chase C. 4

Accession 0001209191-23-002031

CIK 0001260990other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:00 PM ET

Size

4.8 KB

Accession

0001209191-23-002031

Insider Transaction Report

Form 4
Period: 2023-01-03
Leavitt Chase C.
General Counsel/Secretary
Transactions
  • Tax Payment

    Common Stock

    2023-01-03$1.02/sh6,091$6,21381,901 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.

Issuer

Oncternal Therapeutics, Inc.

CIK 0001260990

Entity typeother

Related Parties

1
  • filerCIK 0001777467

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:00 PM ET
Size
4.8 KB